Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2001;3(3):258. doi: 10.1007/s11908-001-0028-1

Hantavirus pulmonary syndrome in the United States

Marilyn Fabbri 1, Melanie J Maslow 1
PMCID: PMC7102107  PMID: 11384556

Abstract

Since the first outbreak of hantavirus pulmonary syndrome (HPS) in 1993, understanding of the vast distribution and potential impact of hantaviruses has grown. At least 277 cases of HPS have been documented in the United States. The full clinical spectrum has yet to be elucidated, and one outbreak suggested the possibility of person-to-person transmission. New research has identified the β-3 integrins as cellular receptors for hantaviruses and has determined the pivotal role of the immune system in pathogenesis. Rapid diagnosis has been facilitated by a new immunoblot assay to detect Sin Nombre virus infection. Treatment remains primarily supportive; however, a placebocontrolled trial of ribavirin is ongoing. Extracorporeal membrane oxygenation may be a potential therapy in severe cases; inhaled nitric oxide needs further study. Vaccines developed against hantaviruses associated with hemorrhagic fever and renal syndrome might be effective against HPS-associated strains.

Keywords: Hemorrhagic Fever With Renal Syndrome, Hantaviral Infection, Peromyscus Maniculatus, Hantaan Virus, Noncardiogenic Pulmonary Edema

References and Recommended Reading

  • 1.Elliot LH, Ksiazek TG, Rollin PE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg. 1994;51:1020–1028. doi: 10.4269/ajtmh.1994.51.102. [DOI] [PubMed] [Google Scholar]
  • 2.Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med. 1994;330:949–955. doi: 10.1056/NEJM199404073301401. [DOI] [PubMed] [Google Scholar]
  • 3.Khan AS, Khabbaz RF, Armstrong LR, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis. 1996;173:1297–1303. doi: 10.1093/infdis/173.6.1297. [DOI] [PubMed] [Google Scholar]
  • 4.Rollin PE, Ksiazek TG, Elliot TG, et al. Isolation of Black Creek Canal virus, a new hantavirus from Sigmodon hispidus in Florida. J Med Virol. 1995;46:35–39. doi: 10.1002/jmv.1890460108. [DOI] [PubMed] [Google Scholar]
  • 5.Khan AS, Spiropoulou CS, Morzunov S, et al. A fatal illness associated with a new hantavirus in Louisiana. J Med Virol. 1995;46:281–286. doi: 10.1002/jmv.1890460320. [DOI] [PubMed] [Google Scholar]
  • 6.Gavrilovskaya I, LaMonica R, Fay M-E, et al. New York 1 and Sin Nombre viruses are serotypically distinct viruses associated with hantavirus pulmonary syndrome. J Clin Microbiol. 1999;37:122–126. doi: 10.1128/jcm.37.1.122-126.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis. 1997;3:95–104. doi: 10.3201/eid0302.970202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Henderson WW, Monroe MC, St Jeor SC, et al. Naturally occurring Sin Nombre virus genetic reassortments. Virology. 1995;214:602–610. doi: 10.1006/viro.1995.0071. [DOI] [PubMed] [Google Scholar]
  • 9.Li D, Schmaljohn AL, Anderson K, et al. Complete nucleotide sequences of the M and S segments of two hantavirus isolates from California: evidence for reassortment in nature among viruses related to hantavirus pulmonary syndrome. Virology. 1995;206:973–983. doi: 10.1006/viro.1995.1020. [DOI] [PubMed] [Google Scholar]
  • 10.Rodriguez LL, Owens JH, Peters CJ, et al. Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology. 1998;242:99–106. doi: 10.1006/viro.1997.8990. [DOI] [PubMed] [Google Scholar]
  • 11.Hart CA, Bennett M. Hantavirus infections: epidemiology and pathogenesis. Microbes Infect. 1999;1:1229–1237. doi: 10.1016/S1286-4579(99)00238-5. [DOI] [PubMed] [Google Scholar]
  • 12.McCaughey C, Hart CA. Hantaviruses. J Med Microbiol. 2001;49:587–599. doi: 10.1099/0022-1317-49-7-587. [DOI] [PubMed] [Google Scholar]
  • 13.Mills JN, Ksiazek TG, Peters CJ, et al. Long-term studies of hantavirus reservoir populations in the Southwestern United States: a synthesis. Emerg Infect Dis. 1999;5:135–142. doi: 10.3201/eid0501.990116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Meyer BJ, Schmaljohn CS. Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol. 2001;8:61–67. doi: 10.1016/S0966-842X(99)01658-3. [DOI] [PubMed] [Google Scholar]
  • 15.Mertz GJ, Hjelle BL, Bryan RT. Hantavirus infection. Adv Intern Med. 1997;42:369–421. [PubMed] [Google Scholar]
  • 16.Schussler JM, Jordan H, Stokoe C, et al. Hantavirus pulmonary syndrome. South Med J. 1999;92:233–235. doi: 10.1097/00007611-199902000-00015. [DOI] [PubMed] [Google Scholar]
  • 17.Butler JC, Peters CJ. Hantaviruses and hantavirus pulmonary syndrome. Clin Infect Dis. 1994;19:387–395. doi: 10.1093/clinids/19.3.387. [DOI] [PubMed] [Google Scholar]
  • 18.Howard MJ, Doyle TJ, Koster FT, et al. Hantavirus pulmonary syndrome in pregnancy. Clin Infect Dis. 1999;29:1538–1544. doi: 10.1086/313513. [DOI] [PubMed] [Google Scholar]
  • 19.Vitek CR, Breiman RF, Ksiazek TG, et al. Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis. 1996;22:824–826. doi: 10.1093/clinids/22.5.824. [DOI] [PubMed] [Google Scholar]
  • 20.Zeitz PS, Butler JC, Cheek JE. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis. 1995;171:864–870. doi: 10.1093/infdis/171.4.864. [DOI] [PubMed] [Google Scholar]
  • 21.Padula PJ, Edelstein A, Miguel SDL, et al. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to person transmission of Andes virus. Virology. 1998;241:323–330. doi: 10.1006/viro.1997.8976. [DOI] [PubMed] [Google Scholar]
  • 22.Centers for Disease Control and Prevention: All about hantaviruses. Accessible at http://www.cdc.gov/ncidod/ diseases/hanta/hps/noframes/caseinfo.htm. Accessed December 2000.
  • 23.Toro J, Vega JD, Khan AS, et al. An outbreak of hantavirus pulmonary syndrome in Chile, 1997. Emerg Infect Dis. 1998;4:687–693. doi: 10.3201/eid0404.980425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Simonsen L, Dalton MJ, Breiman RF, et al. Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. J Infect Dis. 1995;172:729–733. doi: 10.1093/infdis/172.3.729. [DOI] [PubMed] [Google Scholar]
  • 25.Kitsutani PT, Denton RW, Fritz CL, et al. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis. 2001;3:701–705. doi: 10.3201/eid0505.990512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med. 1996;24:252–258. doi: 10.1097/00003246-199602000-00012. [DOI] [PubMed] [Google Scholar]
  • 27.Bustamante EA, Levy H, Simpson SQ. Pleural fluid characteristics in hantavirus pulmonary syndrome. Chest. 1997;112:1133–1136. doi: 10.1378/chest.112.4.1133. [DOI] [PubMed] [Google Scholar]
  • 28.Moolenaar RL, Dalton CD, Lipman HB, et al. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin Infect Dis. 1996;21:643–649. doi: 10.1093/clinids/21.3.643. [DOI] [PubMed] [Google Scholar]
  • 29.Hopkins RO, Larson-Lohr V, Weaver LK, et al. Neuropsychological impairments following hantavirus pulmonary syndrome. J Int Neuropsychol Soc. 1998;4:190–196. doi: 10.1017/S1355617798001908. [DOI] [PubMed] [Google Scholar]
  • 30.Terajima M, Hendershot JD, Kariwa H, et al. High levels of viremia in patients with hantavirus pulmonary syndrome. J Infect Dis. 1999;180:2030–2034. doi: 10.1086/315153. [DOI] [PubMed] [Google Scholar]
  • 31.Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Ann Rev Med. 1999;50:531–545. doi: 10.1146/annurev.med.50.1.531. [DOI] [PubMed] [Google Scholar]
  • 32.Jenison S, Yamada T, Morris C, et al. Characterization of human antibody responses to Four Corners hantavirus infection among patients with hantavirus pulmonary syndrome. J Virol. 1994;68:3000–3006. doi: 10.1128/jvi.68.5.3000-3006.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hjelle B, Jenison S, Torrez-Martinez N, et al. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol. 1997;35:600–608. doi: 10.1128/jcm.35.3.600-608.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bostik P, Winter J, Ksiazek TG, et al. Sin Nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. Emerg Infect Dis. 2001;6:184–187. doi: 10.3201/eid0602.000213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Butler JC, Zaki SR, Khabbaz RF, et al. Hantavirus pulmonary syndrome. Infect Dis Clin Pract. 1995;4:189–192. doi: 10.1097/00019048-199505000-00011. [DOI] [Google Scholar]
  • 36.Mori M, Rothman AL, Kurane I, et al. High levels of cytokineproducing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis. 1999;179:295–302. doi: 10.1086/314597. [DOI] [PubMed] [Google Scholar]
  • 37.Gavrilovskaya IN, Shepley M, Shaw R, et al. B3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A. 1998;95:7074–7079. doi: 10.1073/pnas.95.12.7074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ennis FA, Cruz J, Spiropoulou CF, et al. Hantavirus pulmonary syndrome: CD4 and CD8 cytotoxic T lymphocytes to epitopes on Sin Nombre Virus nucleocapsid protein isolated during acute illness. Virology. 1997;238:380–390. doi: 10.1006/viro.1997.8827. [DOI] [PubMed] [Google Scholar]
  • 39.Bharadwaj M, Nofchissey R, Goade D, et al. Humoral immune responses in the hantavirus pulmonary syndrome. J Infect Dis. 2001;182:43–48. doi: 10.1086/315657. [DOI] [PubMed] [Google Scholar]
  • 40.Chapman LE, Mertz GJ, Peters CJ, et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Antiviral Ther. 1999;4:211–219. doi: 10.1177/135965359900400404. [DOI] [PubMed] [Google Scholar]
  • 41.Crowley MR, Katz RW, Kessler R, et al. Successful treatment of adults with severe hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med. 1998;26:409–414. doi: 10.1097/00003246-199802000-00047. [DOI] [PubMed] [Google Scholar]
  • 42.Rosenberg RB, Waagner DC, Romano MJ, et al. Hantavirus pulmonary syndrome treated with inhaled nitric oxide. Pediatr Infect Dis J. 1998;17:749–752. doi: 10.1097/00006454-199808000-00018. [DOI] [PubMed] [Google Scholar]
  • 43.Hantavirus infection-southwestern United States. Interim recommendations for risk reduction. MMWR Morb Mortal Wkly Rep 1993, 42(RR-11):1-13. [PubMed]
  • 44.Cho H-W, Howard CR. Antibody responses in humans to an inactivated hantavirus vaccine. Vaccine. 1999;17:2569–2575. doi: 10.1016/S0264-410X(99)00057-2. [DOI] [PubMed] [Google Scholar]
  • 45.Chu YK, Jennings GB, Schmaljohn CS. A Vaccinia virusvectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Pumaala virus. J Virol. 1995;69:6417–6423. doi: 10.1128/jvi.69.10.6417-6423.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Schmaljohn CS, Chu YK, Schmaljohn AL, et al. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol. 1990;64:3162–3170. doi: 10.1128/jvi.64.7.3162-3170.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Xu X, Ruo SL, McCormick JB, et al. Immunity to Hantavirus challenge in Meriones unguicalatus induced by vacciniavectored viral proteins. Am J Trop Med Hyg. 1992;47:397–404. doi: 10.4269/ajtmh.1992.47.397. [DOI] [PubMed] [Google Scholar]
  • 48.Hooper JW, Kamrud KI, Elgh F, et al. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology. 1999;255:269–278. doi: 10.1006/viro.1998.9586. [DOI] [PubMed] [Google Scholar]
  • 49.Update: hantavirus pulmonary syndrome — United States, 1993. MMWR Morbid Mortal Wkly Rep 1993, 42:816–820. [PubMed]

Articles from Current Infectious Disease Reports are provided here courtesy of Nature Publishing Group

RESOURCES